Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Pinterest (PINS) Reports Q2 Earnings: What Key Metrics Have to Say
Pinterest (PINS) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, Pinterest (PINS) reported revenue of $998.23 million, up 16.9% over the same period last year. EPS came in at $0.33, compared to $0.29 in the year-ago quarter.

The

Here's What Key Metrics Tell Us About VAREX IMAGING (VREX) Q3 Earnings
Here's What Key Metrics Tell Us About VAREX IMAGING (VREX) Q3 Earnings

For the quarter ended June 2025, VAREX IMAGING (VREX) reported revenue of $203 million, down 2.9% over the same period last year. EPS came in at $0.18, compared to $0.14 in the year-ago quarter.

The

Universal Electronics (UEIC) Q2 Earnings and Revenues Beat Estimates
Universal Electronics (UEIC) Q2 Earnings and Revenues Beat Estimates

Universal Electronics (UEIC) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to a loss of $0.09 per share a year ago

MP Materials Corp. (MP) Reports Q2 Loss, Tops Revenue Estimates
MP Materials Corp. (MP) Reports Q2 Loss, Tops Revenue Estimates

MP Materials Corp. (MP) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.17 per share a year ago. These figures

TaskUs (TASK) Q2 Earnings and Revenues Top Estimates
TaskUs (TASK) Q2 Earnings and Revenues Top Estimates

TaskUs (TASK) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to earnings of $0.31 per share a year ago. These figures are

Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates
Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates

Coherus Oncology (CHRS) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to a loss of $0.14 per share a year ago. These figures

Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates
Health Catalyst (HCAT) Q2 Earnings and Revenues Beat Estimates

Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.12 per share a year ago. These

Goodyear (GT) Reports Q2 Loss, Lags Revenue Estimates
Goodyear (GT) Reports Q2 Loss, Lags Revenue Estimates

Goodyear (GT) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of $0.37. This compares to earnings of $0.19 per share a year ago. These figures are adjusted for

AvePoint, Inc. (AVPT) Meets Q2 Earnings Estimates
AvePoint, Inc. (AVPT) Meets Q2 Earnings Estimates

AvePoint, Inc. (AVPT) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $0.01 per share a year ago. These figures are

Amprius Technologies (AMPX) Reports Q2 Loss, Tops Revenue Estimates
Amprius Technologies (AMPX) Reports Q2 Loss, Tops Revenue Estimates

Amprius Technologies (AMPX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.13 per share a year ago. These

American Healthcare REIT (AHR) Tops Q2 FFO Estimates
American Healthcare REIT (AHR) Tops Q2 FFO Estimates

American Healthcare REIT (AHR) came out with quarterly funds from operations (FFO) of $0.42 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to FFO of $0.33 per share

Onto Innovation (ONTO) Q2 Earnings Lag Estimates
Onto Innovation (ONTO) Q2 Earnings Lag Estimates

Onto Innovation (ONTO) came out with quarterly earnings of $1.25 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.32 per share a year ago. These

Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates

Progyny (PGNY) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.43 per share a year ago. These figures

Metallus (MTUS) Q2 Earnings and Revenues Surpass Estimates
Metallus (MTUS) Q2 Earnings and Revenues Surpass Estimates

Metallus (MTUS) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.15 per share a year ago. These figures

HCI Group (HCI) Q2 Earnings and Revenues Surpass Estimates
HCI Group (HCI) Q2 Earnings and Revenues Surpass Estimates

HCI Group (HCI) came out with quarterly earnings of $5.18 per share, beating the Zacks Consensus Estimate of $4.47 per share. This compares to earnings of $4.21 per share a year ago. These figures

Main Street Capital (MAIN) Q2 Earnings Meet Estimates
Main Street Capital (MAIN) Q2 Earnings Meet Estimates

Main Street Capital (MAIN) came out with quarterly earnings of $0.99 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $1.01 per share a year ago. These figures are

Century Aluminum (CENX) Reports Q2 Loss, Lags Revenue Estimates
Century Aluminum (CENX) Reports Q2 Loss, Lags Revenue Estimates

Century Aluminum (CENX) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of $0.34. This compares to a loss of $0.03 per share a year ago. These figures are

HA Sustainable Infrastructure Capital (HASI) Misses Q2 Earnings and Revenue Estimates
HA Sustainable Infrastructure Capital (HASI) Misses Q2 Earnings and Revenue Estimates

HA Sustainable Infrastructure Capital (HASI) came out with quarterly earnings of $0.6 per share, missing the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.63 per share

AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates

AbCellera Biologics Inc. (ABCL) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.13 per share a year ago. These

VirTra, Inc. (VTSI) Registers a Bigger Fall Than the Market: Important Facts to Note
VirTra, Inc. (VTSI) Registers a Bigger Fall Than the Market: Important Facts to Note

In the latest trading session, VirTra, Inc. (VTSI) closed at $6.97, marking a -3.19% move from the previous day. This move lagged the S&P 500's daily loss of 0.08%. Meanwhile, the Dow lost 0.51%

Wheaton Precious Metals Corp. (WPM) Surpasses Q2 Earnings and Revenue Estimates
Wheaton Precious Metals Corp. (WPM) Surpasses Q2 Earnings and Revenue Estimates

Wheaton Precious Metals Corp. (WPM) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.33 per share a year

PagSeguro Digital Ltd. (PAGS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
PagSeguro Digital Ltd. (PAGS) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest close session, PagSeguro Digital Ltd. (PAGS) was down 1.2% at $8.20. The stock trailed the S&P 500, which registered a daily loss of 0.08%. Elsewhere, the Dow lost 0.51%, while the

Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates
Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates

Evolent Health (EVH) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of $0.09. This compares to earnings of $0.3 per share a year ago. These figures are adjusted

MongoDB (MDB) Registers a Bigger Fall Than the Market: Important Facts to Note
MongoDB (MDB) Registers a Bigger Fall Than the Market: Important Facts to Note

MongoDB (MDB) closed the most recent trading day at $227.86, moving -3.38% from the previous trading session. The stock trailed the S&P 500, which registered a daily loss of 0.08%. Meanwhile, the

Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates
Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates

Kura Oncology (KURA) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of $0.15. This compares to a loss of $0.59 per share a year ago. These figures are adjusted